PRESS RELEASE published on 08/17/2023 at 22:15, 2 years 8 months ago Moderna Clinical Trial Data Confirm Its Updated COVID-19 Vaccine Generates Robust Immune Response in Humans Against Widely Circulating Variants
PRESS RELEASE published on 08/03/2023 at 12:30, 2 years 9 months ago Moderna Reports Second Quarter 2023 Financial Results and Provides Business Updates
PRESS RELEASE published on 07/13/2023 at 13:00, 2 years 9 months ago Moderna to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
PRESS RELEASE published on 07/05/2023 at 13:00, 2 years 10 months ago Moderna Announces Global Regulatory Submissions For Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345
PRESS RELEASE published on 07/03/2023 at 07:00, 2 years 10 months ago Moderna Submits Regulatory Application to the European Medicines Agency for Its Updated COVID-19 Vaccine
PRESS RELEASE published on 06/22/2023 at 22:05, 2 years 10 months ago Moderna Files for FDA Authorization of Its Updated COVID-19 Vaccine
PRESS RELEASE published on 06/05/2023 at 14:00, 2 years 11 months ago Moderna and Merck Announce mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma
PRESS RELEASE published on 06/01/2023 at 22:05, 2 years 11 months ago Moderna to Present at Upcoming Conferences in June 2023
PRESS RELEASE published on 05/30/2023 at 14:00, 2 years 11 months ago Moderna Announces Phase 2 Data on mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, to be Presented at the 2023 ASCO Annual Meeting
PRESS RELEASE published on 05/19/2023 at 13:00, 2 years 11 months ago Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented at the 2023 ASGCT Annual Meeting
Published on 05/12/2026 at 13:50, 22 minutes ago Polaris Renewable Energy Announces Approval of SO1 Agreement by FOMB
Published on 05/12/2026 at 13:30, 42 minutes ago Silver X Mining Begins Trading on OTCQX, Expanding Access to U.S. Investors
Published on 05/12/2026 at 13:30, 42 minutes ago Electric Metals Launches Preliminary Economic Assessment for North Star Manganese Project Downstream HPMSM and EMM Processing Facilities
Published on 05/12/2026 at 13:30, 42 minutes ago Nextech3D.ai Launches Krafty Labs AI Event Marketplace
Published on 05/12/2026 at 13:30, 42 minutes ago CANEX and Gold Basin Resources Announce Arrangement Agreement to Facilitate CANEX’S Acquisition of Remaining Gold Basin Shares
Published on 05/12/2026 at 13:12, 59 minutes ago ABO Energy reaches milestones in its restructuring process and defines areas for action for a successful future positioning
Published on 05/12/2026 at 13:01, 1 hour 10 minutes ago Ahead of the long weekend: How employees in Germany experience shortened working weeks
Published on 05/12/2026 at 12:46, 1 hour 25 minutes ago Niklas Östberg to hand over CEO role at Delivery Hero after fifteen years - Supervisory Board initiates search for successor
Published on 05/12/2026 at 12:45, 1 hour 26 minutes ago EQS-Adhoc: Delivery Hero SE: CEO Succession at Delivery Hero
Published on 05/12/2026 at 14:10, 2 minutes ago LNA SANTE : Répartition de capital et des droits de vote attachés aux actions au 11/05/2026
Published on 05/12/2026 at 08:30, 5 hours 42 minutes ago Eiffage annonce le démarrage des travaux de construction du pôle universitaire du campus Grand Paris Nord à Saint-Ouen-sur-Seine
Published on 05/12/2026 at 08:30, 5 hours 42 minutes ago Eiffage announces launch of the construction work on the university hub of the Grand Paris Nord campus in Saint-Ouen-sur-Seine
